Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hallmarks of Cancer: New Dimensions
Douglas Hanahan
Cancer Discovery (2022) Vol. 12, Iss. 1, pp. 31-46
Open Access | Times Cited: 3308

Showing 1-25 of 3308 citing articles:

Targeting HER2-positive breast cancer: advances and future directions
Sandra M. Swain, Mythili Shastry, Erika Hamilton
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 2, pp. 101-126
Open Access | Times Cited: 544
NF-κB in biology and targeted therapy: new insights and translational implications
Qing Guo, Yizi Jin, Xinyu Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 423
Metastasis
Stefanie Gerstberger, Qingwen Jiang, Karuna Ganesh
Cell (2023) Vol. 186, Iss. 8, pp. 1564-1579
Open Access | Times Cited: 357
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
Qingfang Han, Wenjia Li, Kaishun Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 345
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 321
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Lian Narunsky-Haziza, Gregory D. Sepich‐Poore, Ilana Livyatan, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3789-3806.e17
Open Access | Times Cited: 318
Copper metabolism in cell death and autophagy
Qian‐Li Xue, Rui Kang, Daniel J. Klionsky, et al.
Autophagy (2023) Vol. 19, Iss. 8, pp. 2175-2195
Open Access | Times Cited: 299
BCL-2 protein family: attractive targets for cancer therapy
Deeksha Kaloni, Sarah T. Diepstraten, Andreas Strasser, et al.
APOPTOSIS (2022) Vol. 28, Iss. 1-2, pp. 20-38
Open Access | Times Cited: 275
RNA splicing dysregulation and the hallmarks of cancer
Robert K. Bradley, Olga Anczuków
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 135-155
Open Access | Times Cited: 249
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 214
Programmed Cell Death Tunes Tumor Immunity
Jing Liu, Minjing Hong, Yijia Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 212
Current developments in gastric cancer: from molecular profiling to treatment strategy
María Alsina, Virginia Arrazubi, Marc Díez, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 3, pp. 155-170
Closed Access | Times Cited: 208
Molecular mechanisms of tumor resistance to radiotherapy
Yu Wu, Yingqiu Song, Runze Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 194
Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis
Lei Su, Yunhuan Gao, Rongcun Yang
Cells (2022) Vol. 11, Iss. 15, pp. 2296-2296
Open Access | Times Cited: 193
Biology and therapeutic targeting of vascular endothelial growth factor A
Lorena Pérez, Napoleone Ferrara
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 11, pp. 816-834
Closed Access | Times Cited: 190
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
Inés Marín, Olga Boix, Andrea García-Garijo, et al.
Cancer Discovery (2022) Vol. 13, Iss. 2, pp. 410-431
Open Access | Times Cited: 187
COSMIC: a curated database of somatic variants and clinical data for cancer
Zbysław Sońdka, Nidhi Bindal Dhir, Denise Carvalho‐Silva, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1210-D1217
Open Access | Times Cited: 186
Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 175
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
Cheng‐Liang Kuo, Ananth Ponneri Babuharisankar, Ying‐Chen Lin, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 172
Targeting the tumor stroma for cancer therapy
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
Bacteria in cancer initiation, promotion and progression
Geniver El Tekle, Wendy S. Garrett
Nature reviews. Cancer (2023) Vol. 23, Iss. 9, pp. 600-618
Closed Access | Times Cited: 156
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study
Deborah Schrag, Tomasz M. Beer, Charles H. McDonnell, et al.
The Lancet (2023) Vol. 402, Iss. 10409, pp. 1251-1260
Closed Access | Times Cited: 155
Chronic inflammation and the hallmarks of aging
Jordan J. Baechle, Nan Chen, Priya Makhijani, et al.
Molecular Metabolism (2023) Vol. 74, pp. 101755-101755
Open Access | Times Cited: 147
Cancer cell plasticity during tumor progression, metastasis and response to therapy
Andrea Pérez-González, Kevin Bévant, Cédric Blanpain
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1063-1082
Open Access | Times Cited: 143
YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches
Stefano Piccolo, Tito Panciera, Paolo Contessotto, et al.
Nature Cancer (2022)
Open Access | Times Cited: 142
Page 1 - Next Page

Scroll to top